evans blue has been researched along with Muscular Dystrophy in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barton, ER; Kobinger, GP; Louboutin, JP; Sweeney, HL; Wilson, JM | 1 |
Campbell, KP; Chamberlain, JS; Rafael, JA; Straub, V | 1 |
Baghdiguian, S; Beckmann, JS; Bourg, N; Fardeau, M; Herasse, M; Lefranc, G; Marchand, S; Ono, Y; Richard, I; Roudaut, C; Sébille, A; Sorimachi, H; Stockholm, D; Suel, L | 1 |
Cifuentes-Diaz, C; Frugier, T; Joshi, V; Lacène, E; Melki, J; Moreau, MH; Roblot, N; Tiziano, FD | 1 |
Davies, MJ; Grounds, MD; Hamer, PW; McGeachie, JM | 1 |
5 other study(ies) available for evans blue and Muscular Dystrophy
Article | Year |
---|---|
Correction of the dystrophic phenotype by in vivo targeting of muscle progenitor cells.
Topics: Animals; beta-Galactosidase; Cell Differentiation; Coloring Agents; Dystrophin; Evans Blue; Gene Transfer Techniques; Genetic Therapy; Immunohistochemistry; Lentivirus; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle Fibers, Skeletal; Muscle, Skeletal; Muscular Dystrophies; Necrosis; Phenotype; Stem Cells | 2003 |
Animal models for muscular dystrophy show different patterns of sarcolemmal disruption.
Topics: Animals; Dystrophin; Evans Blue; Humans; Mice; Mice, Inbred mdx; Mice, Mutant Strains; Mice, Transgenic; Muscle Fibers, Skeletal; Muscle, Skeletal; Muscular Dystrophies; Muscular Dystrophy, Animal; Mutagenesis; Mutation; Myocardium; Sarcolemma; Serum Albumin | 1997 |
Loss of calpain 3 proteolytic activity leads to muscular dystrophy and to apoptosis-associated IkappaBalpha/nuclear factor kappaB pathway perturbation in mice.
Topics: Animals; Apoptosis; Calpain; Creatine Kinase; Crosses, Genetic; DNA-Binding Proteins; Evans Blue; Female; Fertility; Gene Deletion; Gene Targeting; Genotype; I-kappa B Proteins; Male; Mice; Mice, Knockout; Muscle Fibers, Skeletal; Muscle, Skeletal; Muscular Dystrophies; NF-kappa B; NF-KappaB Inhibitor alpha; Phenotype; RNA, Messenger; Sarcolemma; Signal Transduction | 2000 |
Deletion of murine SMN exon 7 directed to skeletal muscle leads to severe muscular dystrophy.
Topics: Animals; Biomarkers; Cell Size; Creatine Kinase; Cyclic AMP Response Element-Binding Protein; Cytoskeletal Proteins; Dystrophin; Evans Blue; Exons; Fluorescent Antibody Technique; Membrane Proteins; Mice; Motor Neurons; Muscle Fibers, Skeletal; Muscle, Skeletal; Muscular Atrophy, Spinal; Muscular Dystrophies; Nerve Tissue Proteins; Neuromuscular Junction; RNA-Binding Proteins; Sarcolemma; Sequence Deletion; SMN Complex Proteins; Utrophin | 2001 |
Evans Blue Dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability.
Topics: Animals; Cell Membrane Permeability; Coloring Agents; Evans Blue; Immunohistochemistry; Injections, Intraperitoneal; Injections, Intravenous; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred mdx; Microscopy, Fluorescence; Models, Animal; Muscle Fibers, Skeletal; Muscle, Skeletal; Muscular Dystrophies; Physical Conditioning, Animal | 2002 |